A detailed history of Umpqua Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Umpqua Bank holds 1,505 shares of LLY stock, worth $1.2 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
1,505
Previous 766 96.48%
Holding current value
$1.2 Million
Previous $694 Million 92.26%
% of portfolio
0.49%
Previous 0.27%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$772.14 - $960.02 $570,611 - $709,454
739 Added 96.48%
1,505 $1.33 Billion
Q2 2024

Aug 06, 2024

SELL
$724.87 - $909.04 $10,873 - $13,635
-15 Reduced 1.92%
766 $694 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $462,508 - $618,770
781 New
781 $608 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Umpqua Bank Portfolio

Follow Umpqua Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Umpqua Bank, based on Form 13F filings with the SEC.

News

Stay updated on Umpqua Bank with notifications on news.